|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.32 EUR | -0.38% |
|
-1.98% | -11.12% |
| 12-12 | Sanofi's Qfitlia and Cablivi Approves in China, Expanding Care for Rare Diseases | CI |
| 12-12 | European health regulator recommends approval for GSK's twice-yearly asthma drug | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.38% | -1.98% | -7.87% | +3.25% | -11.12% | -6.56% | -6.31% | +6.11% | +9.03% | 119B | |
| +1.80% | +1.70% | +0.45% | +36.02% | +33.10% | +30.21% | +186.49% | +542.03% | +1,133.65% | 920B | |
| +0.75% | +4.78% | +8.36% | +18.83% | +46.30% | +44.31% | +18.06% | +38.33% | +108.08% | 510B | |
| -0.29% | -1.22% | -3.86% | +2.28% | +25.67% | +28.81% | +35.52% | +110.01% | +313.25% | 395B | |
| -0.35% | +1.90% | +9.28% | +19.77% | +23.99% | +25.12% | +3.11% | +3.65% | +18.79% | 340B | |
| -1.12% | -1.09% | -0.37% | +13.99% | +28.43% | +28.43% | +18.70% | +64.75% | +210.48% | 278B | |
| -0.45% | -1.48% | -0.23% | +6.73% | +18.94% | +20.24% | +24.41% | +29.35% | +26.27% | 254B | |
| +1.30% | +0.58% | +7.93% | +21.12% | +0.82% | -1.67% | -9.57% | +20.90% | +92.33% | 249B | |
| +0.45% | +3.73% | +0.78% | -7.80% | -48.55% | -57.41% | -30.85% | +50.70% | +69.88% | 224B | |
| +0.11% | -3.68% | -5.43% | +14.96% | +21.91% | +17.41% | +16.70% | +39.73% | +104.80% | 171B | |
| -2.28% | -0.68% | -3.83% | +5.11% | +30.35% | +31.08% | +35.66% | +98.16% | +20.36% | 149B | |
| +0.19% | -0.69% | +0.23% | +8.29% | -2.56% | +1.06% | -51.29% | -37.14% | -19.37% | 147B | |
| +1.37% | -0.76% | +4.03% | +14.58% | +12.25% | -2.52% | +47.20% | +101.65% | +284.26% | 115B | |
| +2.36% | +0.50% | +7.77% | +13.44% | -7.34% | -6.04% | -32.24% | -13.69% | -22.49% | 107B | |
| +0.19% | +1.08% | +0.77% | +21.35% | +35.50% | +37.23% | +25.62% | +3.28% | +12.49% | 97.84B | |
| +1.99% | +3.77% | +5.56% | +27.53% | +22.06% | +29.56% | +136.06% | +69.13% | +503.04% | 90.26B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -0.19% | +2.69% | -0.44% | -8.30% | +37.86% | +35.82% | +64.88% | -15.16% | +312.45% | 59.5B | |
| -3.65% | -13.22% | -12.43% | -14.67% | +68.95% | +61.97% | +67.76% | +206.63% | +343.30% | 52.52B | |
| -0.51% | +0.86% | +1.55% | -1.00% | +6.39% | +7.57% | +6.92% | +14.94% | -23.69% | 45.11B | |
| Average | +0.06% | -0.14% | +0.65% | +10.29% | +18.05% | +17.09% | +29.31% | +70.18% | +184.05% | 219.38B | |
| Weighted average by Cap. | +0.42% | +0.76% | +1.66% | +16.37% | +21.56% | +20.39% | +51.43% | +150.11% | +338.49% |
- Stock Market
- Equities
- SAN Stock
- Sector Sanofi
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition